After nearly three years of contraction, venture capital deal volume rose for the third successive quarter in Q4 2025, according to data released this week. But the numbers mask a more complicated story: the market that's recovering is not the market that collapsed.
The $450 billion peak of 2021 was, most analysts now agree, an anomaly driven by historic low interest rates and pandemic-era risk appetite. What's returning is something more selective, more patient, and significantly more concentrated in three sectors: AI infrastructure, climate technology, and biotechnology.
Seed-stage activity remains suppressed. The mid-stage financing that characterised the boom — the Series B and C rounds that could value pre-revenue companies at nine-figure sums — has not returned. What's flowing is primarily late-stage capital, seeking near-term paths to liquidity in a market that has been starved of IPOs.
"We're not back to 2021, and we shouldn't be," said one partner at a top-tier fund, speaking on background. "What we're seeing is the market repricing risk properly. That's healthy, even if it doesn't feel like it to everyone."